MediFind found 254 doctor with experience in Malignant Hypertension near Japan. Of these, 230 are Experienced, 23 are Advanced and 1 are Distinguished.
Yoshifumi Ubara practices in Toranomon, Japan. Ubara is rated as a Distinguished expert by MediFind in the treatment of Malignant Hypertension. Their top areas of expertise are Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Glomerulonephritis, Parathyroidectomy, and Liver Embolization.
Masayuki Yamanouchi practices in Toranomon, Japan. Mr. Yamanouchi is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. His top areas of expertise are Diabetic Nephropathy, Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney Disease, Parathyroidectomy, and Liver Embolization.
Tatsuya Suwabe practices in Toranomon, Japan. Mr. Suwabe is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. His top areas of expertise are Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Enlarged Liver, Liver Embolization, and Parathyroidectomy.
Naoyuki Hasebe practices in Asahikawa, Japan. Hasebe is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. Their top areas of expertise are Fabry Disease, Malignant Hypertension, Hypertension, Ventricular Fibrillation, and Percutaneous Coronary Intervention (PCI).
Naoki Sawa practices in Toranomon, Japan. Mr. Sawa is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. His top areas of expertise are Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Glomerulonephritis, Liver Embolization, and Kidney Transplant.
Naoki Nakagawa practices in Asahikawa, Japan. Mr. Nakagawa is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. His top areas of expertise are Membranoproliferative Glomerulonephritis, Malignant Hypertension, Nephrotic Syndrome, Heart Bypass Surgery, and Percutaneous Coronary Intervention (PCI).
Daisuke Ikuma practices in Toranomon, Japan. Mr. Ikuma is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. His top areas of expertise are Rheumatoid Vasculitis, Glomerulonephritis, Polycystic Kidney Disease, Liver Embolization, and Bone Marrow Transplant.
Kenichi Ohashi practices in Tokyo, Japan. Mr. Ohashi is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. His top areas of expertise are Glomerulonephritis, Nephrosclerosis, Membranoproliferative Glomerulonephritis, Pancreaticoduodenectomy, and Parathyroidectomy.
Keiichi Kinowaki practices in Toranomon, Japan. Kinowaki is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. Their top areas of expertise are Nephrosclerosis, Interstitial Nephritis, Malignant Hypertension, Nephrectomy, and Pancreaticoduodenectomy.
Hiroki Mizuno practices in Osaka, Japan. Mr. Mizuno is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. His top areas of expertise are Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney Disease, Interstitial Nephritis, Liver Embolization, and Kidney Transplant.
Kei Kono practices in Toranomon, Japan. Kono is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. Their top areas of expertise are Glomerulonephritis, Interstitial Nephritis, Membranoproliferative Glomerulonephritis, Splenectomy, and Nephrectomy.
Junichi Hoshino practices in Tokyo, Japan. Mr. Hoshino is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. His top areas of expertise are Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Enlarged Liver, Kidney Transplant, and Parathyroidectomy.
Eiko Hasegawa practices in Toranomon, Japan. Ms. Hasegawa is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. Her top areas of expertise are Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Glomerulonephritis, Kidney Transplant, and Parathyroidectomy.
Masahito Imanishi practices in Osaka, Japan. Imanishi is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. Their top areas of expertise are Malignant Hypertension, Diabetic Nephropathy, Hypertension, and Wilson Disease.
Yutaka Yamaguchi practices in Chiba, Japan. Mr. Yamaguchi is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. His top areas of expertise are Interstitial Nephritis, Glomerulonephritis, Focal Segmental Glomerulosclerosis, Membranoproliferative Glomerulonephritis, and Kidney Transplant.
Takafumi Toyohara practices in Sendai, Japan. Toyohara is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. Their top areas of expertise are Malignant Hypertension, Diabetic Nephropathy, Renovascular Hypertension, Acute Arterial Occlusion of Kidney, and Angioplasty.
Shigeru Shibata practices in Itabashi, Japan. Mr. Shibata is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. His top areas of expertise are Renal Tubular Acidosis, Proximal Renal Tubular Acidosis, Primary Tubular Proximal Acidosis, High Potassium Level, and Nephrectomy.
Takaaki Abe practices in Sendai, Japan. Abe is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. Their top areas of expertise are Renovascular Hypertension, Esophageal Cancer, Diabetic Nephropathy, Angioplasty, and Thrombectomy.
Koichi Kikuchi practices in Sendai, Japan. Mr. Kikuchi is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. His top areas of expertise are Diabetic Nephropathy, Malignant Hypertension, Renovascular Hypertension, Light Chain Deposition Disease (LCDD), and Angioplasty.
Yoshihide Fujigaki practices in Itabashi, Japan. Fujigaki is rated as an Advanced expert by MediFind in the treatment of Malignant Hypertension. Their top areas of expertise are Glomerulonephritis, Interstitial Nephritis, Aminoaciduria, and Focal Segmental Glomerulosclerosis.
Last Updated: 01/09/2026